• HOME

  • ABOUT US

  • OUR TECHNOLOGY

  • SCIENTIFIC TEAM

  • CONTACT

  • More

    Use tab to navigate through the menu items.

    Relevant Papers

    1. UNDERSTANDING THE TECHNOLOGY> Recent Patents on MicroRNA-Induced Pluripotent Stem Cell Generation

    2. Regulation of somatic cell reprogramming through inducible mir-302 expression

    3. MicroRNA miR-302 Inhibits the Tumorigenecity of Human Pluripotent Stem Cells

    4. Mir-302 reprograms human skin cancer cells into a pluripotent ES-cell-like state

    ​

    1. Method of Action
    2. Third Party Efficiency Test (Mice) 

    3. Third Party Efficiency Test (Pig) 

    4. Patents (Mello Biotech).zip

    5. InVitro Toxicity Test

    6. InVivo Toxicity Test

    7. Stability report 1

    8. Stability Report 2

    Support Documentation 

    All Rights Reserverved - RxGenesys Biotech, LLC

    Headquarters

    175 SW, 7th St

    Suite 2102

    Miami, FL 33130